We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Science Strategic Acquisition Corporaiton | NASDAQ:SSAA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.05 | 10.04 | 10.08 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-39930
Science Strategic Acquisition Corp. Alpha
(Exact name of registrant as specified in its charter)
1447 2nd Street
Santa Monica, CA 90401
(310) 393-3024
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one redeemable warrant
Class A common stock, $0.0001 par value
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | x |
Rule 12g-4(a)(2) | ¨ |
Rule 12h-3(b)(1)(i) | x |
Rule 12h-3(b)(1)(ii) | ¨ |
Rule 15d-6 | ¨ |
Rule 15d-22(b) | ¨ |
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Science Strategic Acquisition Corp. Alpha has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: December 23, 2022 | By: | /s/ Michael Jones |
Name: | Michael Jones | |
Title: | Chief Executive Officer |
1 Year Science Strategic Acquis... Chart |
1 Month Science Strategic Acquis... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions